2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatory disorders
CA 2516624 C · Owner: Boyer, Stephen · Inventors: Chen, Jianqing; Smith, Roger A.; Phillips, Barton
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to novel diaryl ureas of formula (I) pharmaceutical , compositions containing such compounds and the use of those compounds or compositions for treating hyper-proliferative and angiogenesis disorders as a , sole agent or in combination with cytotoxic therapies.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 1, 2004 and granted May 14, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 1, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 1, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.